Two Texas compounding pharmacies are the latest to get sued in Eli Lilly’s multistate battle to stop sales of replica ...
A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...
A Delaware federal judge dismissed a lawsuit brought by Eli Lilly, the maker of the blockbuster weight loss drugs Mounjaro and Zepbound, against a telehealth company it accused of “deceptive” ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The pharmacy argued in its ...
Eli Lilly (NYSE:LLY) must pay $183.7M as damages in a lawsuit alleging that the Indiana-based drugmaker defrauded the Medicaid drug pricing program, a federal appeals court ruled on Thursday, ...
US appeals court in Chicago upholds jury verdict, damages Jury found Lilly didn't rebate Medicaid for higher prices Lilly disagrees with decision, plans appeal Sept 11 (Reuters) - A federal appeals ...